TipRanks
Advertisement
Advertisement

SNTI Stock Latest News

Senti Biosciences shareholders approve merger and restructuring moves
Company AnnouncementsSenti Biosciences shareholders approve merger and restructuring moves
7d ago
8K
SNTI
Senti Biosciences Adjourns Meeting To Seek Merger Support
PremiumCompany Announcements
Senti Biosciences Adjourns Meeting To Seek Merger Support
9d ago
8K
SNTI
Senti Biosciences Announces Board and Committee Leadership Change
PremiumCompany Announcements
Senti Biosciences Announces Board and Committee Leadership Change
28d ago
8K
SNTI
Senti Biosciences Secures Equity Commitment Amid Merger Plans
PremiumCompany Announcements
Senti Biosciences Secures Equity Commitment Amid Merger Plans
2M ago
8K
SNTI
Senti Biosciences amends securities agreement, adds note tranche
PremiumCompany Announcements
Senti Biosciences amends securities agreement, adds note tranche
2M ago
8K
SNTI
Senti Biosciences Advances Proxy for Merger and CVR
PremiumCompany AnnouncementsSenti Biosciences Advances Proxy for Merger and CVR
2M ago
8K
SNTI
VOO vs. VTI: Are You Owning the Wrong Vanguard ETF?
Premium
Market News
VOO vs. VTI: Are You Owning the Wrong Vanguard ETF?
3M ago
MU
SPX
Senti Bio announces transaction to spin off Gene-Circuit-enabled pipeline
Premium
The Fly
Senti Bio announces transaction to spin off Gene-Circuit-enabled pipeline
3M ago
SNTI
Senti Biosciences Details New Direct Financial Obligation
PremiumCompany Announcements
Senti Biosciences Details New Direct Financial Obligation
5M ago
8K
SNTI
Senti Biosciences Faces Severe Refinancing and Liquidity Risks from Costly Note Structure
PremiumCompany Announcements
Senti Biosciences Faces Severe Refinancing and Liquidity Risks from Costly Note Structure
5M ago
SNTI
Analyst Maintains Buy on Senti Biosciences, Keeps $12 Price Target on Strengthened Clinical, Regulatory, and Financial Position
PremiumRatings
Analyst Maintains Buy on Senti Biosciences, Keeps $12 Price Target on Strengthened Clinical, Regulatory, and Financial Position
5M ago
SNTI
Senti Bio completes Type B RMAT meeting with FDA on SENTI-202
PremiumThe Fly
Senti Bio completes Type B RMAT meeting with FDA on SENTI-202
5M ago
SNTI
Senti Bio reports Q1 EPS (14c), consensus (36c)
PremiumThe FlySenti Bio reports Q1 EPS (14c), consensus (36c)
5M ago
SNTI
Senti Biosciences Advances SENTI-202 With New FDA Support
Premium
Company Announcements
Senti Biosciences Advances SENTI-202 With New FDA Support
5M ago
8K
SNTI
Senti Biosciences Secures Convertible Note Financing with Celadon
Premium
Company Announcements
Senti Biosciences Secures Convertible Note Financing with Celadon
6M ago
8K
SNTI
Senti Biosciences Plans Tax-Free Holding Company Reorganization
PremiumCompany Announcements
Senti Biosciences Plans Tax-Free Holding Company Reorganization
7M ago
8K
SNTI
Buy Rating on SENTI-202 Driven by Strong Early AML Efficacy and De-Risking Regulatory Designations Despite Financing Overhang
PremiumRatings
Buy Rating on SENTI-202 Driven by Strong Early AML Efficacy and De-Risking Regulatory Designations Despite Financing Overhang
7M ago
SNTI
Senti Bio reports Q4 EPS (53c), consensus (47c)
PremiumThe Fly
Senti Bio reports Q4 EPS (53c), consensus (47c)
7M ago
SNTI
Senti Biosciences Amends Lease, Restructures GeneFab Sublease
PremiumCompany Announcements
Senti Biosciences Amends Lease, Restructures GeneFab Sublease
7M ago
8K
SNTI
Senti Bio completes enrollment in Phase 1 trial of SENTI-202
PremiumThe FlySenti Bio completes enrollment in Phase 1 trial of SENTI-202
8M ago
SNTI
Promising Potential of SENTI-202 in Treating Acute Myeloid Leukemia: A Buy Recommendation Despite Financial Risks
Premium
Ratings
Promising Potential of SENTI-202 in Treating Acute Myeloid Leukemia: A Buy Recommendation Despite Financial Risks
10M ago
SNTI
Promising Phase 1 Results and Favorable Safety Profile Drive Buy Rating for Senti Biosciences’ SENTI-202 in AML Treatment
Premium
Ratings
Promising Phase 1 Results and Favorable Safety Profile Drive Buy Rating for Senti Biosciences’ SENTI-202 in AML Treatment
11M ago
SNTI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >